Plastic pollution is a growing global problem that harms both the environment and human health. Plastics don’t break down easily, so they accumulate in landfills, air, water, and soil. Tiny plastic particles, known as microplastics and nanoplastics, are especially concerning because they can enter living organisms, including humans, and build up in the body. These particles can cause inflammation, disrupt hormones and gut health, and increase disease risk.
Recent research shows that nanoplastics may also impact the brain, possibly by traveling from the gut to the brain and causing inflammation. They’ve even been found in the brains of people with dementia, raising concerns about their role in neurological diseases.
Recent research has drawn attention to Parkinson’s Disease (PD) as a condition potentially worsened by environmental toxins, including nanoplastics. These tiny plastic particles may interfere with cellular energy production and trigger inflammation, both key factors in PD development. Animal studies have shown that ingesting nanoplastics can lead to Parkinson’s-like symptoms, disrupt biological rhythms, and interact with proteins involved in the disease. In this study, nanoplastics even helped spread PD-related damage in the brain. It also revealed that nanoplastics entering through the digestive system can travel to the brain and intensify PD symptoms. Since PD not only impacts the brain but also affects metabolism, researchers explored how nanoplastics might disrupt digestion and other bodily systems, offering new insights into how the disease progresses.
Polystyrene Nanoplastics and Their Impact on Gut and Brain Health
Researchers found that polystyrene nanoplastics, commonly used in packaging, can significantly affect gut health, especially when combined with a Parkinson’s-related protein (A53T αS). In mice, this combination damaged the gut lining, reduced protective cells, and increased harmful bacteria, particularly in the small intestine.
One harmful bacterium, Desulfovibrio, increased in response to nanoplastics and is linked to brain diseases like Parkinson’s and Alzheimer’s. Nanoplastics also upset the balance between major gut bacteria groups and increase inflammation-triggering substances like LPS, which may contribute to brain damage.
In the colon, the overall number of bacteria stayed the same, but their types and behavior changed. A drop in Akkerman Sia, a beneficial bacterium, was observed in mice exposed to the Parkinson’s protein. Nanoplastics also altered gut chemistry, affecting nearly 5,800 chemical compounds (metabolites) involved in digestion, immunity, and brain function. These changes were linked to liver stress, inflammation, mood disorders, and muscle health.
The gut and liver work together to maintain overall health. When gut bacteria are disrupted, it can lead to liver inflammation. In this study, mice exposed to nanoplastics showed signs of liver irritation, likely caused by gut imbalance. Importantly, nanoplastics helped the Parkinson’s protein move from the gut to the brain, where it triggered inflammation, a key factor in brain cell damage. This supports the idea that Parkinson’s Disease may begin in the gut and spread to the brain.
Key chemicals affected by nanoplastics included:
- Phenylacetyl glycine – linked to liver stress and heart disease
- 7-ketodeoxycholic acid – may affect gut-brain communication.
- Psychosine – tied to brain disorders
- 5-hydroxyindole – associated with anxiety and depression
These findings suggest that tiny plastic particles in the environment may be more harmful than previously thought. Nanoplastics can disrupt gut health, trigger inflammation, and potentially worsen conditions like Parkinson’s Disease by affecting the entire body, not just the brain. In the mice exposed to both nanoplastics and the Parkinson’s-related protein, researchers observed changes in key body chemicals linked to brain function, liver health, and inflammation. These included:
- CDP, important for brain cell energy and communication.
- GDCA, a bile acid that helps control inflammation.
- Sulfur dioxide (SO₂), which can cause oxidative stress when levels are too high.
These changes suggest that nanoplastics may interfere with the gut-liver-brain connection, contributing to the progression of Parkinson’s Disease.
Health Risks at Low Exposure Levels
Even small amounts of nanoplastics, like what has been found in human tissues, can cause brain damage in animal studies. People with existing health conditions or children may be especially vulnerable, highlighting the need for regulations and safer alternatives to reduce plastic exposure.
What Still Needs to Be Studied
While the study shows strong links between nanoplastics and health problems, more research is needed to:
- Understand whether the effects are specific to Parkinson’s or due to general toxicity.
- Determine how different types of plastics affect the body.
- Explore differences between males and females.
- Test treatments that could prevent or reverse damage.
These findings emphasize the importance of long-term studies and targeted research to fully understand the health impacts of environmental nanoplastics.